Literature DB >> 11756760

CD117 (KIT): a diverse protein with selective applications in surgical pathology.

Pamela C Gibson1, Kumarasen Cooper.   

Abstract

CD 117 (KIT) is a transmembrane, tyrosine kinase growth factor receptor which is expressed on numerous diverse fetal and adult cells including hematopoietic cells, mast cells, melanocytes, germ cells, and the interstitial cells of Cajal. Its expression in tumors is also diverse, but with selective use and attention to specific staining patterns, this marker is useful in the identification of gastrointestinal stromal tumors, mast cell tumors, and seminomatous germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756760     DOI: 10.1097/00125480-200201000-00007

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  13 in total

1.  Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man.

Authors:  Adam O Burzynski; Alfredo Luis Valente; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-04-24       Impact factor: 4.176

2.  Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.

Authors:  Syed Rizwan Hussain; Sunil G Babu; Syed Tasleem Raza; Pradyumn Singh; Faisal Ahmed; Hena Naqvi; Farzana Mahdi
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 3.  Melanotic schwannoma with drop metastases to the caudal spine and high expression of CD117 (c-kit).

Authors:  Rabih G Tawk; Dongfeng Tan; Laszlo Mechtler; Robert A Fenstermaker
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 4.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

5.  KIT expression in fetal, normal adult, and neoplastic renal tissues.

Authors:  D Miliaras; F Karasavvidou; A Papanikolaou; D Sioutopoulou
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 6.  Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib.

Authors:  Gunhild Mechtersheimer; Gerlinde Egerer; Manfred Hensel; Ralf J Rieker; Martin Libicher; Thomas Lehnert; Roland Penzel
Journal:  Virchows Arch       Date:  2004-01-20       Impact factor: 4.064

7.  Tyrosine kinase receptor expression in thymomas.

Authors:  John D Henley; Oscar W Cummings; Patrick J Loehrer
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-05       Impact factor: 4.553

8.  Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients.

Authors:  Hailiang Zhang; Dingwei Ye; Xudong Yao; Bo Dai; Shilin Zhang; Yijun Shen; Yao Zhu; Huirong Mao
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-23       Impact factor: 4.553

9.  Expression of KIT (CD117) in biphasic pulmonary blastoma. Novel data on histogenesis.

Authors:  T Hansen; F Bittinger; C Kortsik; B Wagner; C J Kirkpatrick
Journal:  Lung       Date:  2003       Impact factor: 2.584

10.  The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade.

Authors:  Parvin Mahzouni; Mohsen Jafari
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.